Wednesday, 11 November 2026
M
Meridian Globe
Live briefing
Gilbert + Tobin rethinks the business of law with AI— OpenAI 官方博客Thailand tightens environmental rules for large data centers— 日经 Nikkei AsiaSoftBank swings to first-half loss as AI hopes face new setbacks— 日经 Nikkei AsiaHonda bets on hybrids as mainstay of US electrification into early 2030s— 日经 Nikkei AsiaMicrosoft says tech firms must 'prove' AI data centers benefit locals— 日经 Nikkei AsiaChina offers to buy more Papua New Guinea gas after Taiwan cuts purchases— 日经 Nikkei AsiaJapan's Akita AI data center seen anchoring tech hub, boosting tax revenue— 日经 Nikkei AsiaTSMC is seeing 'insatiable' demand for chips, executive tells Nikkei Forum— 日经 Nikkei AsiaGilbert + Tobin rethinks the business of law with AI— OpenAI 官方博客Thailand tightens environmental rules for large data centers— 日经 Nikkei AsiaSoftBank swings to first-half loss as AI hopes face new setbacks— 日经 Nikkei AsiaHonda bets on hybrids as mainstay of US electrification into early 2030s— 日经 Nikkei AsiaMicrosoft says tech firms must 'prove' AI data centers benefit locals— 日经 Nikkei AsiaChina offers to buy more Papua New Guinea gas after Taiwan cuts purchases— 日经 Nikkei AsiaJapan's Akita AI data center seen anchoring tech hub, boosting tax revenue— 日经 Nikkei AsiaTSMC is seeing 'insatiable' demand for chips, executive tells Nikkei Forum— 日经 Nikkei Asia

Pharmacological chaperone treatment with Cystadane in aspartylglucosaminuria: an open-label, phase Ib/II trial

Source Nature 生命科学11h ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Global
Language
English
Item ID
science-e9ff2e17

Comments 0 comments

No comments yet. Be the first.

Pharmacological chaperone treatment with Cystadane in aspartylglucosaminuria: an open-label, phase Ib/II trial · Meridian Globe